Metabolites › RAFHKEAPVIWLJC-KQOHHTLASA-N

rifamycin O

(2'S,12'Z,14'E,16'S,17'S,18'R,19'R,20'R,21'S,22'R,23'S,24'E)-5',17',19'-trihydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-1',4,6',11'-tetraoxo-1',2'-dihydro-6'H-spiro[1,3-dioxolane-2,9'-[2,7](epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan]-21'-yl acetate

RAFHKEAPVIWLJC-KQOHHTLASA-N CHEBI:16324 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
RAFHKEAPVIWLJC-KQOHHTLASA-N
InChI Key
RAFHKEAPVIWLJC-KQOHHTLASA-N
IUPAC name
(2'S,12'Z,14'E,16'S,17'S,18'R,19'R,20'R,21'S,22'R,23'S,24'E)-5',17',19'-trihydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-1',4,6',11'-tetraoxo-1',2'-dihydro-6'H-spiro[1,3-dioxolane-2,9'-[2,7](epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan]-21'-yl acetate
Preferred name
rifamycin O
INN name
—
Synonym
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, gamma-lactone
ChEBI
CHEBI:16324

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles